SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?


To: yosi s who wrote (643)4/22/1998 7:30:00 PM
From: InvestorLady  Read Replies (1) | Respond to of 1491
 
Westergaard is no great tout. They have a not-so great and questionable track record and are basically paid touts posing as uninterested investment advisors for very speculative stocks.

I was very sad to see Westergaard take an interest in this stock. It made me want to sell. If PARS is paying them to do this, they should research the record of this company. Westergaard is the equivalent of tabloid coverage for stocks. Shock value and flashy words but the substance is lacking, imho. I fear that association with them can hurt PARS more than help.

Perhaps they will do a good job with PARS but like the Natioinal Enquirer doing a quality story with good insight and research, and winning journalism awards it is rare if it happens at all, from what I have read.

As a shareholder of PARS I question their judgement on this, if indeed PARS paid them for this coverage. And I would think they could do much better. If PARS had nothing to do with it, well, exposure is exposure.

PARS deserves much better coverage given their marketing partners, don't you think?

What other news letters are discussing PARS?

Lady